Intervention

trabeculectomy

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 10 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials10

Recruiting0

Common conditions8

Lead sponsors shown9

Clinical trials

10 shown

Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Primary Angle Closure GlaucomaNCT02964676 · 2017-01-01

UNKNOWN

The Expression of Matrix Metalloproteinase 13, Tissue Inhibitor of Metalloproteinases 3, and Calcium-sensing Receptor in Human Trabecular MeshworkNCT02638181 · 2013-07-01

COMPLETED

Biomechanical Changes After TrabeculectomyNCT02287545 · 2013-02-01

COMPLETED

Astigmatism Post-trabeculectomyNCT01711190 · 2012-01-01

COMPLETED

Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence TomographyNCT01391676 · 2011-03-01

COMPLETED

Trabeculectomy Versus CanaloplastyNCT01228799 · 2010-06-01

COMPLETED

Prospective Randomized Study Comparing Ex-PRESS to TrabeculectomyNCT01263561 · 2009-04-01

COMPLETED

Combined Phacotube vs Phacotrabeculectomy:A Randomized Controlled TrialNCT00273221 · 2005-07-01

UNKNOWN

Comparison of Phacotrabeculectomy and Trabeculectomy in the Treatment of Primary Angle-closure Glaucoma (PACG)NCT01298635 · 2005-01-01

COMPLETED

A Comparison Between Deep Sclerectomy and TrabeculectomyNCT00595855 · 1997-10-01

COMPLETED

Common conditions

Glaucoma6 Cataract2 Glaucoma, Angle-Closure2 Canaloplasty1 Filtering Blebs1 Glaucoma, Primary1 Open-angle Glaucoma1 Trabeculectomy1

Leading sponsors

Technische Universität Dresden2 Lv Yingjuan1 National University Hospital, Singapore1 Shanghai Eye Disease Prevention and Treatment Center1 Sun Yat-sen University1 Universitaire Ziekenhuizen KU Leuven1 University Eye Hospital, Würzburg1 University of Parma1 University of Toronto1

Trial status mix

COMPLETED8

UNKNOWN2

Phase mix

NA6

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.